Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

137.48
0.0000
Pre-market: 138.921.44+1.05%04:21 EDT
Volume:2.42M
Turnover:334.25M
Market Cap:262.31B
PE:20.78
High:139.43
Open:138.76
Low:137.46
Close:137.48
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.57
T/O Rate:0.13%
Dividend:4.67
Dividend Rate:3.39%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.31
PE(LYR):19.23

Loading ...

Movement Alert|Novartis Rises 3.11% in Pre-Market Trading, Multiple Pipeline Catalysts Drive Positive Sentiment

Market Focus
·
Jun 11

Bank of America Securities Remains a Buy on Novartis (NVS)

TIPRANKS
·
Jun 11

Novartis announces biomarker cohort in study of del-brax met primary endpoint

TIPRANKS
·
Jun 11

Novartis Says Early-to-Mid Stage Study for Muscular Dystrophy Drug Meets Main Goal

MT Newswires Live
·
Jun 11

Novartis $12 Billion Bet on Avidity Is Starting to Pay Off -- Market Talk

Dow Jones
·
Jun 11

Novartis Could Move Forward Neuromuscular Drug Approval After Early Data -- Market Talk

Dow Jones
·
Jun 11

Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk

Dow Jones
·
Jun 10

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

Dow Jones
·
Jun 09

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones
·
Jun 09

Argus Research Reaffirms Their Buy Rating on Novartis (NVS)

TIPRANKS
·
Jun 06

Movement Alert|Novartis Rises 3.13% in Regular Trading, Positive Cosentyx Phase 3 Data Boosts Shares Amid Broad Pharma Rally

Market Focus
·
Jun 05

Novartis Says Cosentyx Shows Sustained Remission in Phase 3 Trial

MT Newswires Live
·
Jun 04

Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial

MT Newswires Live
·
Jun 03

Movement Alert|Novartis Falls 3.06% in Regular Trading, Trading at $144.97

Market Focus
·
Jun 01

Novartis's Next Prostate Cancer Therapy Could Raise Bar for Treatment -- Market Talk

Dow Jones
·
Jun 01

Novartis announces results on rPFS improvements across subgroups with Pluvicto

TIPRANKS
·
Jun 01

Experimental Novartis radiopharma drug shows promise in early study

Reuters
·
May 31

A New, Powerful Cholesterol-Lowering Drug Is on the Horizon -- WSJ

Dow Jones
·
May 28

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live
·
May 18